about
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritisDisruption of K(2P)6.1 produces vascular dysfunction and hypertension in miceEchocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease.Pulmonary hypertension in children with Evans syndrome.Hemolysis-associated pulmonary hypertension in thalassemia.Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsMagnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersHemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailabilityPlatelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobinDiastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.Cerebrovascular disease associated with sickle cell pulmonary hypertension.Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease.Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.Modern treatment of thalassaemia intermedia.Heart disease in thalassemia intermedia.Treatment of pulmonary hypertension in three patients with ß-thalassemia intermedia using pulmonary arterial hypertension-specific medications.Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.Nitric oxide metabolites and arginase I levels in β-thalassemic patients: an Egyptian study.Pulmonary hypertension in hemolytic anemiasHemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.Pulmonary function, CT and echocardiographic abnormalities in sickle cell disease.Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative
P2860
Q21195404-3CCC6FA2-E284-4195-9E44-63B2C39F8972Q28589505-2311077C-2881-48E0-BA37-198A599DF0E5Q30447935-1B4BC14C-3ADD-4ECE-8168-7F4915806AD2Q33379056-000139F9-581A-4709-8345-4E3146771774Q34474615-283C679E-4342-4D81-8926-5C46158E1D86Q34992760-19F42AC8-F792-46FE-8E5B-8A25E1EC30B4Q35438051-AA13569B-3816-465A-8DAC-FC92C99255CCQ35590733-EDC7A728-4012-4081-B07D-90046561E6E5Q35750972-02C02EAB-3A4D-4FE4-A5DD-0E25A507A171Q35990633-39DBAAFF-94B8-476E-81BF-76A19A49FC52Q36151344-CF224187-277F-45F0-B41A-9F17890E895DQ36330543-BBF2AB1B-F3C5-4173-8616-6D74BD5E65D5Q36392798-CC6FEF77-492F-4A2E-BE88-F4A9E91A67EEQ36419650-F89AAB4F-48E3-4226-9F6B-D9DEAE4620BAQ36428347-1FCB78F0-3676-4DD4-9301-F57F0B1D0617Q36780187-D615F89D-0CA5-4032-BFE9-85E8CEBDF54AQ36848269-47809B85-54DF-4D75-8F55-BF7F519CEC72Q37650441-CC1BDD15-1F17-44FB-9EC4-011147923E43Q37680252-89B4FE3D-A6A6-40FB-A7B1-35FCFF21267BQ37854465-A42C397F-1579-4E2F-A894-8D65C5106243Q38987725-49809B47-FD3B-4E48-B827-EAE37526302FQ42415504-614449A5-E86E-43E4-B2B6-82160DF6BEEBQ42575662-3A0240D2-732C-4A49-8C59-8E2A9DE7F361Q43180474-7C716EE8-E128-419E-B1F9-3BD41DBED741Q47799282-5BF328E0-37F7-457F-8116-2AA9F84D7478Q53059961-E2FE9F6C-0822-4C2D-836F-9EB0A25E6461Q57165817-554B3EE2-7F2A-45B5-BEB5-12B4A3EB0825
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Pulmonary hypertension in sickle cell disease.
@en
type
label
Pulmonary hypertension in sickle cell disease.
@en
prefLabel
Pulmonary hypertension in sickle cell disease.
@en
P356
P1476
Pulmonary hypertension in sickle cell disease.
@en
P304
P356
10.1056/NEJMP038250
P407
P577
2004-02-01T00:00:00Z